This typically involves showing: The drug use was an isolated incident, merely experimental
Concerns have been raised about serious side effects (e.g., gastrointestinal paralysis)
N-Acetylglucosamine (NAG): An amino sugar that offers similar exfoliation properties to direct acids
The compound belongs to a class of short regulatory peptides investigated in experimental models exploring cellular longevity pathways, peptide signalling networks and molecular regulatory systems
It should not be used as a drug or injection, since the FDA has not approved it for human use
Its levels decline naturally with age, and this decline is accelerated by chronic conditions including HIV/AIDS, cancer, type 2 diabetes, Parkinson's disease, and hepatitis